Imatinib Mesylate 00832-0532-09

Package NDC

00832-0532-09

Manufacturer: Upsher-Smith Laboratories, Llc
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 17, 2024
Application: ANDA212135

Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Imatinib Mesylate	100 mg/1

Drug Class

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]

Selected Package

00832-0532-09Selected

90 TABLET in 1 BOTTLE (0832-0532-09)